Formulating the blueprint for effective clinical labelling in ultra-low temperature conditions
The emergence of biologics has contributed towards impressive advancements in the treatment of multiple disease types; offering improved quality of life and better health outcomes to millions of patients worldwide.
For one biotechnology company, the need to maintain ultra-low temperature conditions was a necessity, but came with many challenges.
Download Almac’s latest Case Study to find out how they built an effective strategy to respond to this unique set of requirements.